AXTI has moved fast. AXT, Inc. shares are up 68% in a month and surged 21% on May 1 alone. Now three distinct data streams are pulling in opposite directions — and the options market just flashed a clear warning sign.
Wedbush's Matt Bryson has raised his price target on AXTI twice in three days. On April 29, the target jumped from $28 to $80. On May 1, it went straight to $93 — an Outperform maintained both times. The stock currently trades around $96, already past that revised target. No other analyst has moved yet. B. Riley's Dave Kang sits at Neutral with a $21 target. The divide is stark.
The bull case centres on AXT's niche position in compound semiconductor substrates. Demand from datacentre and passive optical network applications remains strong. The bear case flags InP capacity expansion from Coherent and Lumentum as a structural headwind. Both are plausible. The tape sided with the bulls — at least for now.
The put/call ratio hit 0.59 on May 1. That's the highest reading in a month and sits near the 52-week peak of 0.60. The z-score against the 20-day mean is 2.93 — a nearly three-standard-deviation move. Options traders are hedging at a rate not seen since before this rally started. After a 21% single-day pop, that defensive tilt is notable.
Short interest stands at 17.6% of free float. That's up 15.3% over the past week and 16.2% over the past month — rising alongside the price. Short sellers are not covering. They are adding. Nearly 7.9 million shares are currently short, close to the highest levels in the data window.
The lending market remains relaxed. Availability is ample — no squeeze pressure from the borrow side. Cost to borrow sits at just 0.40% annualised, down 25% over the past month. Shorts are paying almost nothing to hold their positions. There is no mechanical force pushing them out.
Every insider trade on record is a sale. CEO Morris Young, CFO Gary Fischer, and Lead Independent Director Jesse Chen all sold in mid-March — when the stock was trading in the $45–$51 range. Net insider sales over 90 days total roughly $43M. The CEO sold more than 194,000 shares across three days alone. These were sizeable disposals at prices well below today's levels.
Three forces are now in tension: analysts chasing a runaway stock, options traders hedging against a reversal, and short sellers holding firm at elevated levels without borrow pressure. EPS momentum scores rank at the 97th and 100th percentile for 30- and 90-day windows — the fundamental story has clearly shifted. But at a P/E of 211x and EV/EBITDA near 157x, the valuation leaves little room for disappointment. Next earnings are scheduled for July 30.
See the live data behind this article on ORTEX.
Open AXTI on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.